AUG 23, 2017 05:39 AM PDT
Jury Awards $417M in Baby Powder Cancer Case
WRITTEN BY: Xuan Pham
3 18 1826

A California patient claimed her ovarian cancer was caused by Johnson & Johnson’s baby powder product. She sued, and in a historic ruling, the court ordered the company to fork over a record $417 million in damages.

Image credit: Lucas Jackson / Reuters

The patient is 63-year-old Eva Echeverria who has been faithfully using the baby powder on her body since she was 11. Specifically, she used the powder for feminine hygiene purposes, a practice that Johnson & Johnson (J & J) did not caution against until very recently in 2016. By the time J & J made the warning public, Echeverria had already been battling ovarian cancer for 10 years.

Echeverria believed her terminal ovarian cancer was linked to the prolonged use of the talc powder. And in court, her lawyers alleged that J & J had known about such cancer link for some time, but had failed to warn consumers adequately of the product’s risks.

Meanwhile, J & J countered that the science behind the link between talc powder and ovarian cancer is inconclusive. They also reiterated science that supports the safety of the talc powder.

In the end, the jury agreed with Echeverria, and J & J was ordered to pay $70 million in compensatory damages, and another $347 million in punitive damages. All told, the payout of $417 will be the largest sum that’s been awarded in the string of talcum cases plaguing J & J.

Last year, the company lost three similar cases in Missouri, resulting in a total payout of over $300 million in damages. And in May, in another talc-related lawsuit, the company was ordered to pay $110.5 million to a 62-year-old ovarian cancer patient in Virginia.

But according to Echeverria’s lawyers, the case is not about money; rather, it’s about bringing awareness to a potentially carcinogenic product that most of us have in our houses right now.

“Mrs. Echeverria is dying from this ovarian cancer and she said to me all she wanted to do was to help the other women throughout the whole country who have ovarian cancer for using Johnson & Johnson for 20 and 30 years,” said Mark Robinson, Echeverria’s attorney. “She really didn’t want sympathy. She just wanted to get a message out to help these other women.”

"Johnson & Johnson had many warning bells over a 30 year period but failed to warn the women who were buying its product," he said.

J & J plans to appeal the Echeverria cases and others. "We will appeal today's verdict because we are guided by the science," said Carol Goodrich, spokesperson for Johnson & Johnson Consumer Inc.

Additional sources: BBC

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
FEB 27, 2018
Clinical & Molecular DX
FEB 27, 2018
Onsite Imaging Services for Olympic Athletes with Injuries
One scientist and his team from the Boston University School of Medicine emphasize how important imaging exams are for athletes, especially those participa
APR 07, 2018
Cardiology
APR 07, 2018
Which individual cells are to blame for atherosclerosis?
The immune cells that are partly responsible for clogging arteries in a disease called atherosclerosis are under investigation. From the University of Wurz
APR 27, 2018
Clinical & Molecular DX
APR 27, 2018
Stomach Pain Is A Warning Sign for Meningitis
Simply looking out for the classic warning signs of a meningococcal infection may cause some cases to go unnoticed - at first. A new study from the Institu
MAY 01, 2018
Cancer
MAY 01, 2018
The Microfluidic Device: Future Replacement for Bone Marrow Biopsy in Multiple Myeloma
Researchers have developed a microfluidic device that can detect circulating plasma cells in whole blood; therefore, negating the need for a bone marrow biopsy to diagnose Multiple Myeloma.
MAY 23, 2018
Technology
MAY 23, 2018
Building Block Medical Test Is Reusable
MIT's Little Devices Lab has created a more affordable solution called Ampli blocks that consists of modular diagnostic kits, which can be re-oriented and reused.
MAY 29, 2018
Microbiology
MAY 29, 2018
Environmental Factors Drive Belly Fat Buildup
Abdominal fat is a major risk factor for disease. New work could help find those at risk for increased belly fat, and help reverse that trend.
Loading Comments...